How hungry fat cells could someday starve cancer to death
Liposuction and plastic surgery aren't often mentioned in the same breath as cancer. But they are the inspiration for a new ...
ReShape Lifesciences® Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation Technology
ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company was granted a key international patent from the ...
EurekAlert!6d
‘Pushing the boundaries of radiation treatment’: Breakthrough in pancreatic cancer therapy advances to clinical trials
A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for ...
GEN6d
Pancreas Protein May Be a Protector against Alzheimer’s Disease
People with diabetes have a higher risk of developing Alzheimer's disease (AD) raising a possible link between the cells that ...
Humacyte and Pluristyx Announce Gene Editing Partnership to Support BioVascular Pancreas (BVP™) Development Using iPSCs
Pluristyx has developed a clinical-grade manufacturing process for using a licensed Mad7 gene editing technology to block Human Leukocyte Antigen (HLA) markers expression. Humacyte is optimizing a ...
Pharmaceutical Technology19d
CDE grants BTD to Innovent’s IBI343 for pancreatic cancer
The Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has granted breakthrough therapy designation (BTD) to Innovent Biologics’ IBI343as a monotherapy ...
clinicaltrialsarena20d
German PEI approves enrolment in cohort 5 of Oncolytics’ pancreatic cancer trial
The combination is intended to treat subjects with newly diagnosed pancreatic ductal adenocarcinoma. Credit: SewCreamStudio/Shutterstock. The Paul-Ehrlich-Institute ...
pancan20d
Pancreatic Cancer Diagnoses and Mortality Rates Climb; Five-Year Survival Rate for Pancreatic Cancer Stalls at 13%
Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for Patients LOS ANGELES, Calif. – (January 16, 2025) – After ...
The New England Journal of Medicine21d
KRAS Oncoprotein Signaling in Cancer
The model, which is predominantly based on genetic ... the rapidly accelerating fibrosarcoma (RAF) effector pathway in pancreatic ductal adenocarcinoma (PDAC) models, with its signaling diversity ...